Department of Anesthesiology, Chengdu Women's and Children's Central Hospital, Chengdu, China,
Department of Anesthesiology, Chengdu Women's and Children's Central Hospital, Chengdu, China.
Respiration. 2020;99(3):264-276. doi: 10.1159/000501045. Epub 2019 Jul 22.
Lung recruitment maneuvers (LRMs) may reduce mortality and improve oxygenation in patients with acute respiratory distress syndrome (ARDS). However, the existing literature provides controversial conclusions.
To determine whether LRMs have benefits on ARDS patients. Searching Methods: We searched relevant studies in PubMed, EMBASE, Medline, and the Cochrane Library up to May 2018. We considered for inclusion all prospective and randomized controlled trials which compared LRMs and non-LRM in adult patients with ARDS. We collected data about in-hospital mortality, 28-day mortality, the length of ICU and hospital stay, PaO2/FiO2, and FiO2.
Ten trials including 3,025 patients were analyzed. No significant difference was found in the hospital and 28-day mortality, as well as the length of ICU stay and oxygen requirement, even undergoing subgroup analysis. However, the results of this meta-analysis showed a significant benefit of LRMs for shortening the length of hospital stay (mean difference, MD = -1.75; 95% CI, -3.40 to -0.09; p = 0.04; p for heterogeneity = 0.3, I2 = 18%) and improving PaO2/FiO2 ratio on the third day (MD = 52.72; 95% CI, 18.77-86.67; p = 0.002), but with extremely high heterogeneity (p for heterogeneity <0.0001, I2 = 99%).
LRMs do not produce significant reduction of mortality in patients with ARDS but may shorten the length of hospital stay and improve oxygenation on the third day. However, the results must be interpreted cautiously as most studies were on multiple intervention exposures.
肺复张手法(LRMs)可能降低急性呼吸窘迫综合征(ARDS)患者的死亡率并改善氧合。然而,现有的文献提供了有争议的结论。
确定 LRMs 是否对 ARDS 患者有益。
我们在 PubMed、EMBASE、Medline 和 Cochrane 图书馆中检索了截至 2018 年 5 月的相关研究。我们纳入了所有比较 LRMs 和非 LRM 在成人 ARDS 患者中的前瞻性随机对照试验。我们收集了关于院内死亡率、28 天死亡率、ICU 和住院时间、PaO2/FiO2 和 FiO2 的数据。
纳入了 10 项试验共 3025 例患者。LRMs 并未降低院内和 28 天死亡率,也未降低 ICU 入住时间和氧需求,即使进行了亚组分析。然而,这项荟萃分析的结果表明,LRMs 显著缩短了住院时间(均数差,MD=-1.75;95%置信区间,-3.40 至 -0.09;p=0.04;异质性 p=0.3,I2=18%),并改善了第 3 天的 PaO2/FiO2 比值(MD=52.72;95%置信区间,18.77-86.67;p=0.002),但存在极高的异质性(p<0.0001,I2=99%)。
LRMs 并未显著降低 ARDS 患者的死亡率,但可能缩短住院时间并改善第 3 天的氧合。然而,由于大多数研究都涉及多种干预措施,因此必须谨慎解释这些结果。